1 Answers
Palbonix Capsule contains Palbociclib
Palbonix Capsule uses for
Palbociclib is a kinase inhibitor indicated for the treatment of hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer in combination with:
- An aromatase inhibitor as initial endocrine based therapy in postmenopausal women; or
- Fulvestrant in women with disease progression following endocrine therapy.
Palbociclib capsules are taken orally with food in combination with an aromatase inhibitor or fulvestrant.
- Recommended starting dose: 125 mg once daily taken with food for 21 days followed by 7 days off treatment.
- Dosing interruption and/or dose reductions are recommended based on individual safety and tolerability.
Read more here Palbonix
1610 views
Answered